All In MedTech

Device Trial Radar · NCT03782116

Stress Incontinence Trial With Elitone Device

Randomized Controlled Study of Efficacy of Elitone Device For the Treatment of Mild-Moderate Stress Urinary Incontinence

Last checked: Nov 20, 2026Latest source record: Jan 13, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

87

Actual

Start

Sep 1, 2018

Primary completion

Mar 31, 2019

Study completion Mar 31, 2019

Sponsor

Lead sponsor
Elidah, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Dec 20, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Female only, from 21 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized controlled study in which subjects are assigned to either a treatment group or a control (sham) group. Pre- and post-study outcome measures evaluate the change in incontinence episodes on women with mild-moderate stress urinary incontinence.

Conditions

  • Stress Urinary Incontinence

Interventions

  • Transcutaneous electrical stimulation (Elitone)Device

    Transcutaneous perineal area electrical stimulation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy Assessed by Percent Reduction in Urinary Incontinence EpisodesTime frame: 12 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Nationwide At-Home study

    Monroe, Connecticut

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.